- Home
- LTH vs RFL Comparison
LTH vs RFL Comparison
Compare LTH & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTH
- RFL
- Stock Information
- Founded
- LTH 1992
- RFL 2017
- Country
- LTH United States
- RFL United States
- Employees
- LTH 42000
- RFL 31
- Industry
- LTH Hotels/Resorts
- RFL Real Estate
- Sector
- LTH Consumer Discretionary
- RFL Finance
- Exchange
- LTH Nasdaq
- RFL Nasdaq
- Market Cap
- LTH 6.3B
- RFL 48.4M
- IPO Year
- LTH 2021
- RFL N/A
- Fundamental
- Price
- LTH $29.65
- RFL $1.47
- Analyst Decision
- LTH Buy
- RFL
- Analyst Count
- LTH 13
- RFL 0
- Target Price
- LTH $34.42
- RFL N/A
- AVG Volume (30 Days)
- LTH 1.9M
- RFL 130.3K
- Earning Date
- LTH 05-08-2025
- RFL 06-13-2025
- Dividend Yield
- LTH N/A
- RFL N/A
- EPS Growth
- LTH 174.52
- RFL N/A
- EPS
- LTH 0.96
- RFL N/A
- Revenue
- LTH $2,730,319,000.00
- RFL $706,000.00
- Revenue This Year
- LTH $14.57
- RFL N/A
- Revenue Next Year
- LTH $10.86
- RFL N/A
- P/E Ratio
- LTH $29.76
- RFL N/A
- Revenue Growth
- LTH 18.58
- RFL 156.73
- 52 Week Low
- LTH $16.55
- RFL $1.27
- 52 Week High
- LTH $34.99
- RFL $2.47
- Technical
- Relative Strength Index (RSI)
- LTH 49.95
- RFL 51.31
- Support Level
- LTH $28.29
- RFL $1.28
- Resistance Level
- LTH $29.59
- RFL $1.41
- Average True Range (ATR)
- LTH 0.83
- RFL 0.09
- MACD
- LTH -0.01
- RFL 0.02
- Stochastic Oscillator
- LTH 63.56
- RFL 90.48
About LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.